IMMTECH INT INC has a total of 35 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are ACTINOVA LTD, TULANE EDUCAT FUND INC and ZLB BIOPLASMA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | Australia | 8 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Canada | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Potempa Lawrence A | 34 |
#2 | Radosevich James A | 7 |
#3 | Liao Hans H | 6 |
#4 | Anderson Byron E | 5 |
#5 | Kresl John J | 4 |
#6 | Crump Becky L | 3 |
#7 | Diehl Edward E | 2 |
#8 | Bean Pamela | 1 |
#9 | Pankow Mark L | 1 |
#10 | Makhlouf Samar | 1 |
Publication | Filing date | Title |
---|---|---|
WO0010593A1 | USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS | |
AU6019599A | Use of mcrp to enhance immune responses | |
AU6130299A | Use of mcrp for delivery of materials into cells | |
US6239099B1 | Methods of treating viral infections | |
US5874238A | Mutant protein and methods and materials for making and using it | |
AU1287595A | A mutant protein and methods and materials for making and using it | |
US5702904A | Immunoassay for identifying alcoholics and monitoring alcohol consumption | |
AU6252294A | A mutant protein and methods and materials for making and using it | |
US5547931A | Methods of stimulatory thrombocytopoiesis using modified C-reactive protein | |
AU3146893A | Method of treating viral infections | |
US5283238A | Methods of treating cancer using modified C-reactive protein | |
US5405832A | Method of treating non-streptococcal bacterial infections |